Christopher Bishop

Professor

Binghamton University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Christopher Bishop is a faculty member at Binghamton University in the United States. His research primarily focuses on Parkinson's disease, particularly exploring the interplay of neurotransmitters and their impact on motor behavior and dyskinesia. His recent work includes studies on the effects of genetic modifications on dyskinesia and the assessment of microstructural brain changes in Parkinson's models.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Jack Lipton

Professor and Founding Chair

Michigan State University

UNITED STATES

View details

Fredric Manfredsson

Associate Professor

Barrow Neurological Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Bishop

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson’s disease

Effects of genetic knockdown of the serotonin transporter on established L-DOPA-induced dyskinesia and gene expression in hemiparkinsonian rats

The effects of L-DOPA on gait abnormalities in a unilateral 6-OHDA rat model of Parkinson's disease

Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats

Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia.

Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.

Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.

Collaborators (2)

Jack Lipton

Fredric Manfredsson

Make your next move.